Form 4 for PRVA Privia Health Group, Inc.
Accepted 2024-09-12 00:00:00 ET · period of report 2024-09-10 · accession 0001759655-24-000125 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-12 | 2024-09-10+ | PRVA | Mehrotra Parth | CEO, Dir | M - OptEx | $2.00 | +252.5K | 349.0K | +262% | +$505.0K |
| D | 2024-09-12 | 2024-09-10 | PRVA | Mehrotra Parth | CEO, Dir | S - Sale+OE | $18.50 | -135.1K | 247.8K | -35% | -$2.50M |
| DM | 2024-09-12 | 2024-09-10+ | PRVA | Mehrotra Parth | CEO, Dir | M - OptEx | $0.00 | -252.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value per share | 2024-09-10 | M | A | 56,027 | $2.00 | 303,798 | D | — | — | |
| 2 | Common | Common Stock, $0.01 par value per share | 2024-09-10 | M | A | 60,520 | $2.00 | 364,318 | D | — | — | |
| 3 | Common | Common Stock, $0.01 par value per share | 2024-09-10 | M | A | 18,595 | $2.00 | 382,913 | D | — | — | |
| 4 | Common | Common Stock, $0.01 par value per share | 2024-09-10 | S | D | 135,142 | $18.50 | 247,771 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.37 to $18.73 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 5 | Common | Common Stock, $0.01 par value per share | 2024-09-11 | M | A | 48,645 | $2.00 | 296,416 | D | — | — | |
| 6 | Common | Common Stock, $0.01 par value per share | 2024-09-11 | M | A | 16,144 | $2.00 | 365,106 | D | — | — | |
| 7 | Common | Common Stock, $0.01 par value per share | 2024-09-11 | M | A | 52,546 | $2.00 | 348,962 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Purchase) | 2024-09-10 | M | D | 60,520 | $0.00 | 52,546 | D | $2.00 · — to 2034-12-04 | 60,520 Common Stock, $0.01 par value per share | (F3) All stock options are fully vested and exercisable. |
| 9 | Derivative | Stock Option (Right to Purchase) | 2024-09-10 | M | D | 56,027 | $0.00 | 48,645 | D | $2.00 · — to 2033-08-27 | 56,027 Common Stock, $0.01 par value per share | (F3) All stock options are fully vested and exercisable. |
| 10 | Derivative | Stock Option (Right to Purchase) | 2024-09-10 | M | D | 18,595 | $0.00 | 16,144 | D | $2.00 · — to 2035-09-07 | 18,595 Common Stock, $0.01 par value per share | (F3) All stock options are fully vested and exercisable. |
| 11 | Derivative | Stock Option (Right to Purchase) | 2024-09-11 | M | D | 48,645 | $0.00 | 0 | D | $2.00 · — to 2033-08-27 | 48,645 Common Stock, $0.01 par value per share | (F3) All stock options are fully vested and exercisable. |
| 12 | Derivative | Stock Option (Right to Purchase) | 2024-09-11 | M | D | 52,546 | $0.00 | 0 | D | $2.00 · — to 2034-12-04 | 52,546 Common Stock, $0.01 par value per share | (F3) All stock options are fully vested and exercisable. |
| 13 | Derivative | Stock Option (Right to Purchase) | 2024-09-11 | M | D | 16,144 | $0.00 | 0 | D | $2.00 · — to 2035-09-07 | 16,144 Common Stock, $0.01 par value per share | (F3) All stock options are fully vested and exercisable. |